🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hypothesis: 3,4-Diaminopyridine base (3,4-DAP) improves Lambert-Eaton Myast...
Status
Completed
Location
University of California at Davis
Start Date
2012-01
Trial ID
NCT01511978
Treatments Being Tested
This randomized, double-blind, controlled, outpatient two-period, two-treat...
Status
Completed
Location
UCLA Department of Neurology
Start Date
2016-01
Trial ID
NCT02562066
Treatments Being Tested
Primary: The primary objective of this study under the original protocol w...
Status
Approved For Marketing
Location
UCLA
Start Date
TBD
Trial ID
NCT02189720
Treatments Being Tested
A new drug called 3,4-Diaminopyridine (3,4-DAP) is currently under investig...
Status
No Longer Available
Location
University of California, Davis
Start Date
TBD
Trial ID
NCT00704925
Treatments Being Tested
The main purpose for this study is to provide access to 3,4 DAP, a drug whi...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2004-02
Trial ID
NCT02090725
Treatments Being Tested
A two-period, two-treatment, crossover study to evaluate the safety, tolera...
Status
Completed
Location
Neurological Institute Carlo Besta
Start Date
2019-01-21
Trial ID
NCT03781479
Treatments Being Tested
A Phase 3 study to evaluate the efficacy and safety of Amifampridine Phosph...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01377922
Treatments Being Tested
Lambert Eaton Myasthenic Syndrome (LEMS) is rare neurological disorder that...
Status
No Longer Available
Location
Columbia University Medical Center
Start Date
2005-05
Trial ID
NCT01378546
Treatments Being Tested
Evaluate the long-term safety of amifampridine phosphate in patients with M...
Status
Terminated
Location
Cleveland Clinic
Start Date
2018-06-11
Trial ID
NCT03579966
Treatments Being Tested
To learn more about the effect of 3, 4-Diaminopyridine (3,4-DAP) on patient...
Status
Approved For Marketing
Location
University of Colorado
Start Date
TBD
Trial ID
NCT01825395
Treatments Being Tested